These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38035921)

  • 81. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension.
    Catena C; Bernardi S; Sabato N; Grillo A; Ermani M; Sechi LA; Fabris B; Carretta R; Fallo F
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):389-93. PubMed ID: 22796347
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome.
    Kositamongkol C; Charernboon T; Chaisathaphol T; Washirasaksiri C; Auesomwang C; Sitasuwan T; Charatcharoenwitthaya P; Phisalprapa P
    Medicine (Baltimore); 2021 Nov; 100(44):e27640. PubMed ID: 34871234
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Duplex ultrasound derived maximal systolic acceleration can be a reliable and rapid alternative to ankle brachial pressure indices for the diabetic population with lower extremity arterial disease; a prospective, observational cohort study.
    Williamson HM; Bartlett M; Desai M
    JRSM Cardiovasc Dis; 2022; 11():20480040211070481. PubMed ID: 35083041
    [No Abstract]   [Full Text] [Related]  

  • 84. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.
    Hamaguchi M; Takeda N; Kojima T; Ohbora A; Kato T; Sarui H; Fukui M; Nagata C; Takeda J
    World J Gastroenterol; 2012 Apr; 18(13):1508-16. PubMed ID: 22509083
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
    Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
    Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hidden dangers revealed by misdiagnosed peripheral arterial disease using ABPI measurement.
    Formosa C; Cassar K; Gatt A; Mizzi A; Mizzi S; Camileri KP; Azzopardi C; DeRaffaele C; Falzon O; Cristina S; Chockalingam N
    Diabetes Res Clin Pract; 2013 Nov; 102(2):112-6. PubMed ID: 24209599
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by
    Lee HJ; Lee CH; Kim S; Hwang SY; Hong HC; Choi HY; Chung HS; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Metabolism; 2017 Feb; 67():72-79. PubMed ID: 28081780
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
    Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
    Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Low-grade albuminuria associated with brachial-ankle pulse wave velocity in young adults with type 2 diabetes mellitus in China.
    Huang L; Yang L; Zhang S; Liu D; Yan X; Yan S
    Diabetes Metab Res Rev; 2015 Mar; 31(3):262-8. PubMed ID: 25139614
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High ankle brachial index predicts high risk of cardiovascular events amongst people with peripheral artery disease.
    Golledge J; Moxon JV; Rowbotham S; Pinchbeck J; Quigley F; Jenkins J
    PLoS One; 2020; 15(11):e0242228. PubMed ID: 33180875
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Melo JV; Santos TRM; Leite NC; Salles GF
    Cardiovasc Diabetol; 2021 Feb; 20(1):54. PubMed ID: 33639945
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
    PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population.
    Kim NH; Park J; Kim SH; Kim YH; Kim DH; Cho GY; Baik I; Lim HE; Kim EJ; Na JO; Lee JB; Lee SK; Shin C
    Heart; 2014 Jun; 100(12):938-43. PubMed ID: 24721975
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease.
    Kumari S; Porwal YC; Gupta R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443534
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
    Behairy MA; Sherief AF; Hussein HA
    Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.
    Dvorak K; Hainer R; Petrtyl J; Zeman M; Vareka T; Zak A; Sroubkova R; Svestka T; Vitek L; Bruha R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):442-8. PubMed ID: 25004910
    [TBL] [Abstract][Full Text] [Related]  

  • 100. NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?
    Villela-Nogueira CA; Leite NC; Cardoso CR; Salles GF
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.